Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral ...

Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful ...

Explore the Kelkar Shah Model's vision for India's tax system, including a unified GST, dual tax structure, and proposals for income, corporate, and wealth tax ...

Meme coins Pepe (PEPE) and SPX6900 (SPX) edge higher at press time on Monday, signaling a bullish start to the week, after ...

There has been greater pressure on banks' NIMs due to a downward repricing of External Benchmark Lending Rates amid front ...

Tickets are now on sale online for Leeds United’s pre-season friendly against Villareal at Elland Road next month. Daniel ...